Evidence map›Paper›PMID 34003304›Full record

ArticleDiabetologia2021

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes.

Craig A Beam, Eleni Beli, Clive H Wasserfall, Stephanie E Woerner, Megan T Legge, Carmella Evans-Molina, Kieran M McGrail, Ryan Silk, Maria B Grant, Mark A Atkinson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Craig A BeamDepartment of Biomedical Sciences, Homer Stryker MD School of Medicine, Western Michigan University, Kalamazoo, MI, USA. craig.beam@med.wmich.edu.
Eleni BeliWellcome Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast, NI, UK. E.Beli@qub.ac.uk.
Clive H WasserfallDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
Stephanie E WoernerIndiana University Center for Diabetes and Metabolic Diseases, Indianapolis, IN, USA.
Megan T LeggeIndiana University Center for Diabetes and Metabolic Diseases, Indianapolis, IN, USA.
Carmella Evans-MolinaIndiana University Center for Diabetes and Metabolic Diseases, Indianapolis, IN, USA.
Kieran M McGrailDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
Ryan SilkWellcome Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast, NI, UK.
Maria B GrantDepartment of Ophthalmology, University of Alabama, Birmingham, AL, USA.
Mark A AtkinsonDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
Linda A DiMeglioIndiana University Center for Diabetes and Metabolic Diseases, Indianapolis, IN, USA.
Indiana University School of MedicineUniversity of Florida · USIndiana University – Purdue University Indianapolis · USQueen's University Belfast · GBRichard L. Roudebush VA Medical Center · USUniversity of Alabama at Birmingham · USWestern Michigan University · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Translation CoreP30DK097512 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Carmella Evans-Molina · 2015 to 2026
$17.4M
The Integrated Stress Response in Human Islets During Early T1DU01DK127786 · NIDDK · UNIVERSITY OF CHICAGO · PI EVANS-MOLINA, CARMELLA, MIRMIRA, RAGHAVENDRA G · 2020 to 2025
$7.1M
Mechanisms of Beta Cell Function in Health and DiseaseR01DK093954 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA · 2011 to 2019
$3.5M
β cell miRNAs Function as Molecular Hubs of Type 1 Diabetes PathogenesisR01DK127308 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA · 2021 to 2024
$1.7M
NCATS NIH HHS UL1 TR001108NIDDK NIH HHS P30 DK097512NIDDK NIH HHS R01 DK093954NIDDK NIH HHS R01 DK127308NIDDK NIH HHS U01 DK127786
6 · The paper itself

Abstract

aims/hypothesisThe circadian clock influences both diabetes and immunity. Our goal in this study was to characterise more thoroughly the circadian patterns of immune cell populations and cytokines that are particularly relevant to the immune pathology of type 1 diabetes and thus fill in a current gap in our understanding of this disease.

methodsTen individuals with established type 1 diabetes (mean disease duration 11 years, age 18-40 years, six female) participated in a circadian sampling protocol, each providing six blood samples over a 24 h period.

resultsDaily ranges of population frequencies were sometimes large and possibly clinically significant. Several immune populations, such as dendritic cells, CD4 and CD8 T cells and their effector memory subpopulations, CD4 regulatory T cells, B cells and cytokine IL-6, exhibited statistically significant circadian rhythmicity. In a comparison with historical healthy control individuals, but using shipped samples, we observed that participants with type 1 diabetes had statistically significant phase shifts occurring in the time of peak occurrence of B cells (+4.8 h), CD4 and CD8 T cells (~ +5 h) and their naive and effector memory subsets (~ +3.3 to +4.5 h), and regulatory T cells (+4.1 h). An independent streptozotocin murine experiment confirmed the phase shifting of CD8 T cells and suggests that circadian dysrhythmia in type 1 diabetes might be an effect and not a cause of the disease. CONCLUSIONS/

interpretationFuture efforts investigating this newly described aspect of type 1 diabetes in human participants are warranted. Peripheral immune populations should be measured near the same time of day in order to reduce circadian-related variation.

Indexed as

AdolescentAdultAnimalsB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChronobiology DisordersCircadian ClocksCircadian RhythmDendritic CellsDiabetes Mellitus, Type 1FemaleFlow CytometryHumansImmune SystemInterleukin-6IL6 protein, humanInterleukin-6Circadian rhythmsClinicalImmune cellsType 1 diabetes

Identifiers

PMID34003304
PMCPMC8245361
OpenAlexW3162992666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.